secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001104659-26-032332
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Healthcare to acquire Breathe Right brand portfolio for $1.045B
--------------------------------------------------------------------------------

- Acquisition includes Breathe Right, Dimetapp, Anbesol brands; trailing revenue $200M, EBITDA $95M.
- Purchase price $1.045B cash; net ~$900M after $150M anticipated tax benefits.
- Implied multiple of 11.0x EBITDA (9.5x net of tax benefits); accretive to gross/EBITDA margins and EPS.
- Expected pro-forma net leverage ~4.0x at closing; target below 3.0x by fiscal 2028.
- Transaction expected to close in first half fiscal 2027, subject to HSR clearance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000110465926032332/0001104659-26-032332-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000110465926032332/tm269430d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-032332

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer